Medication info
Aldermy 40mg (Telmisartan)

Aldermy 40mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
white or almost white, biconvex round tablets
Packaging
Blister - 30 tablets/blister [10 tablets/blister x 3]
Approval status
Active

MFDS item code 201906883 · Approved 2019.09.27 · Insurance code 656005830,665508400

Summary

Main use
Treatment of essential hypertension, reduction and prevention of cardiovascular disease risk
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan once daily, taken orally with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine once daily, taken orally with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, reduction and prevention of cardiovascular disease risk

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It also helps in reducing the risk of death from myocardial infarction, stroke, and cardiovascular disease in high-risk patients aged 55 years and over, especially those with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or those with end-organ damage due to diabetes. Therefore, it is effectively used not only for hypertension but also for reducing cardiovascular risk.

How to take

Adult dose

1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan once daily, taken orally with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine once daily, taken orally with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause severe harm to the fetus during pregnancy, so it should be stopped immediately if pregnancy is confirmed. It should be avoided in pregnant women, nursing mothers, patients with severe liver impairment, specific vascular edema patients, and severe renal impairment patients. Elderly patients, patients with hyperkalemia, mild to moderate liver impairment, and those with heart and kidney-related diseases should take this medication with caution. Blood pressure, kidney function, potassium levels, etc. should be monitored regularly during use, and if any abnormal symptoms appear, consult medical staff immediately. This medication may enhance the effects of other antihypertensives, so it is essential to inform healthcare providers of any other medications currently being taken, especially if combined with ACE inhibitors, aliskiren, or potassium-sparing diuretics, as there may be an increased risk of severe side effects. Symptoms such as severe hypotension, vascular edema, liver dysfunction, kidney impairment, and hyperkalemia may occur; if any abnormal symptoms arise, the medication should be stopped immediately and medical treatment sought. Caution is also needed when driving or operating machinery, as dizziness or fainting may occur. It is not recommended for children and adolescents under 18 years of age due to the lack of established safety and efficacy. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur; immediate medical attention should be sought for appropriate treatment. When storing, keep out of reach of children and avoid humidity.

Side effects

  • Upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
Show 121 more
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • vertigo
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver enzyme abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased blood creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • swelling of the face
  • lips
  • pharynx
  • larynx
  • tongue
  • severe hyperkalemia
  • renal failure
  • shock
  • syncope due to hypotension
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • respiratory distress
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • palpitations
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • bowel vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

white or almost white, biconvex round tablets

Package unit

Blister - 30 tablets/blister [10 tablets/blister x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.